type 2 diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance in muscle and adipose tissues leads to decreased glucose uptake, causing hyperglycemia. Despite normal or elevated insulin levels, cells do not respond effectively, impairing glucose utilization.

• Secondary mechanism: Pancreatic β-cell dysfunction results in inadequate insulin secretion relative to the degree of insulin resistance, further exacerbating hyperglycemia. Over time, β-cells may become exhausted and their function declines.

• Key complication: Chronic hyperglycemia can cause vascular damage, leading to complications such as diabetic neuropathy, retinopathy, and nephropathy, increasing the risk of cardiovascular diseases.

Patient Profile

Demographics:

57-year-old female, office manager

History:

• Key past medical history: Diagnosed with type 2 diabetes 8 years ago, hypertension for 10 years, high cholesterol

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and blurred vision

• Key symptoms: Frequent urination, numbness in the feet, occasional dizziness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 180 mg/dL after fasting

Section 1

Initial Assessment Findings:

During a comprehensive assessment, the nurse notes that the patient exhibits signs of diabetic neuropathy, characterized by numbness and tingling in her feet, which have progressively worsened over the past few months. Upon performing a monofilament test, there is diminished sensation in the distal areas of both feet, suggesting peripheral neuropathy. Additionally, the patient's blurred vision prompts a visual acuity test, revealing decreased visual clarity in both eyes. An ophthalmoscopic examination shows signs indicative of early diabetic retinopathy, such as microaneurysms and mild retinal edema. The patient's blood pressure remains elevated at 150/95 mmHg despite adherence to antihypertensive therapy, highlighting the potential for ongoing vascular complications.

The nurse also conducts a thorough review of the patient's lab results, noting an increased HbA1c level of 8.4%, indicating poor glycemic control over the past three months. Renal function tests reveal a slightly elevated creatinine level of 1.3 mg/dL and microalbuminuria, suggesting early nephropathy. These findings, combined with the patient's symptoms and history, point to a need for more aggressive management of her diabetes and associated conditions to prevent further complications.

Given the current assessment, the healthcare team considers revising the patient's treatment plan. This may include adjusting her medications to better control her blood glucose levels, blood pressure, and lipid profile. Additionally, the inclusion of a diabetic educator and a nutritionist in her care team is recommended to enhance lifestyle modifications and medication adherence. These steps are crucial to managing her progressing diabetic complications and improving her overall health outcomes.

Section 2

Change in Patient Status:

Two weeks following the adjustment of her treatment plan, the patient returns for a follow-up visit. Initially, she reports feeling slightly better with fewer episodes of blurred vision and increased energy levels. However, during the visit, she mentions experiencing intermittent chest discomfort and occasional palpitations, particularly during mild exertion. This new symptom prompts the nurse to perform a cardiac assessment. The patient's heart rate is noted to be irregular, with an occasional skipped beat, and her blood pressure remains elevated at 148/92 mmHg. Given the potential cardiac implications, the healthcare team decides to conduct an electrocardiogram (ECG) to investigate further.

The ECG results reveal occasional premature ventricular contractions (PVCs), suggesting an underlying cardiac arrhythmia, possibly exacerbated by her poorly controlled diabetes and hypertension. Concerned about the cardiovascular risk, the team recommends a cardiology consultation to evaluate the need for further diagnostic testing, such as a stress test or echocardiogram, to assess cardiac function. Meanwhile, her medication regimen is reviewed to ensure optimal management of her blood pressure and glucose levels, and the addition of a beta-blocker is considered to address her arrhythmia and provide cardiac protection.

This development underscores the interconnected nature of diabetes-related complications and emphasizes the need for comprehensive management strategies. The healthcare team recognizes the importance of continued monitoring and patient education, focusing on the signs and symptoms of cardiac issues and the critical role of lifestyle modifications. These steps aim to mitigate the progression of her condition and prevent further complications, ultimately leading to improved health outcomes for the patient.

Section 3

New Diagnostic Results:

Following the cardiology consultation, the patient undergoes a series of diagnostic tests to evaluate her cardiac function more thoroughly. An echocardiogram reveals mild left ventricular hypertrophy, an indication of long-standing hypertension. Additionally, the stress test shows evidence of exercise-induced ischemia, suggesting that the patient's coronary arteries are not supplying enough blood to the heart muscle during physical activity. These findings are concerning, as they highlight the potential development of coronary artery disease, a common complication in patients with type 2 diabetes.

Concurrent laboratory tests further elucidate her condition. The patient's HbA1c level remains elevated at 8.5%, indicating suboptimal glucose control. Her lipid profile reveals dyslipidemia with an LDL cholesterol level of 160 mg/dL, an HDL of 38 mg/dL, and triglycerides at 220 mg/dL. These results, combined with her elevated blood pressure and recent cardiac findings, underscore the significant cardiovascular risk she faces. In light of these diagnostic results, the healthcare team emphasizes the need for an aggressive and multifaceted approach to her management. This includes intensifying pharmacologic therapy to optimize blood pressure, lipid control, and glucose levels, while also reinforcing the importance of lifestyle interventions such as diet modification, increased physical activity, and smoking cessation, if applicable.

The patient is educated on the relationship between her diabetes and cardiovascular health, empowering her to take an active role in her care. The team collaborates to tailor a comprehensive care plan that addresses all aspects of her health, with regular follow-ups to monitor her progress and adjust treatment as necessary. This proactive approach aims to stabilize her condition, prevent further cardiac complications, and improve her overall quality of life.

Section 4

Several weeks into the implementation of the comprehensive care plan, the patient returns for a follow-up visit. During the initial assessment, the nurse notes several important findings. The patient's blood pressure has improved to 138/86 mmHg, demonstrating a positive response to the intensified antihypertensive regimen. However, she reports experiencing intermittent episodes of dizziness, particularly when standing up quickly. This suggests a possible side effect of her medications, indicating the need for careful titration to balance efficacy with safety.

The patient's weight remains stable, but she expresses frustration with her dietary adjustments, indicating that adherence to the recommended low-carbohydrate, heart-healthy diet has been challenging. Despite these hurdles, she has managed to incorporate more physical activity into her daily routine, as evidenced by her self-reported increase in walking and participation in a local swimming class. Her commitment to enhancing her lifestyle, despite obstacles, is commendable and plays a crucial role in her overall management strategy.

Lab results from this visit reveal a slight improvement in her lipid profile, with LDL cholesterol decreasing to 145 mg/dL and triglycerides reducing to 180 mg/dL, though her HDL remains low at 40 mg/dL. Her HbA1c has decreased marginally to 8.3%, but remains above the target range, indicating that further refinement of her glucose-lowering therapy may be necessary. These findings prompt the healthcare team to consider adjustments to her medication regimen, possibly including the introduction of a GLP-1 receptor agonist to enhance glycemic control and confer additional cardiovascular benefits. This ongoing evaluation and modification of her treatment plan underscore the dynamic nature of managing type 2 diabetes with cardiovascular complications, necessitating careful coordination and patient engagement.

Section 5

During the follow-up visit, the nurse conducts a comprehensive assessment and notes that the patient is experiencing increased frequency and severity of dizziness, now accompanied by occasional palpitations and mild fatigue. These symptoms raise concern for potential orthostatic hypotension, a known complication of antihypertensive medication adjustments. The nurse performs orthostatic vital signs, revealing a drop in blood pressure to 110/70 mmHg from a standing position, confirming the suspicion. This necessitates a careful review of her current antihypertensive regimen to optimize her blood pressure control while preventing adverse effects. The healthcare team considers reducing the dose of her beta-blocker or exploring alternative medications with a lower risk of orthostatic hypotension.

In addition to these findings, the patient's recent lab results indicate a worsening of renal function, with her estimated glomerular filtration rate (eGFR) decreasing to 55 mL/min/1.73 m² from a previous 60 mL/min/1.73 m². This decline suggests the onset of diabetic nephropathy, a common complication of diabetes that requires timely intervention. The team discusses the importance of strict glycemic and blood pressure control to slow the progression of kidney disease. Introducing an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB) is considered to provide renal protection and further manage her blood pressure.

These developments emphasize the need for a multidisciplinary approach to her care, involving the coordination of her primary care physician, endocrinologist, and possibly a nephrologist. The patient is counseled on the significance of ongoing monitoring and adherence to her treatment plan, as well as the importance of reporting any new or worsening symptoms. Her commitment to managing her condition remains pivotal, highlighting the collaborative nature of chronic disease management and the necessity for continued patient education and support. Moving forward, the healthcare team plans more frequent follow-ups to closely monitor her renal function and overall response to the adjusted treatment strategy.